These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22785528)

  • 41. Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis.
    Kundrick A; Kirby J; Ba D; Leslie D; Olsen N; Foulke G
    Semin Arthritis Rheum; 2019 Aug; 49(1):140-144. PubMed ID: 30482435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary.
    Garin E; Prigent-Lejeune F; Lesimple T; Barge ML; Rousseau C; Devillers A; Bouriel C; Habiba MT; Bernard AM; Bridji B; Resche I
    Cancer Invest; 2007 Jun; 25(4):232-9. PubMed ID: 17612933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unknown primary tumors: detection with dual-modality PET/CT--initial experience.
    Gutzeit A; Antoch G; Kühl H; Egelhof T; Fischer M; Hauth E; Goehde S; Bockisch A; Debatin J; Freudenberg L
    Radiology; 2005 Jan; 234(1):227-34. PubMed ID: 15564390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
    Jacene HA; Stearns V; Wahl RL
    Clin Nucl Med; 2006 Jul; 31(7):379-81. PubMed ID: 16785802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis.
    Patel P; Finger PT
    Am J Ophthalmol; 2012 Apr; 153(4):661-8. PubMed ID: 22264690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
    Shinohara M; Tomita M; Ohira S; Nishimura A
    Hokkaido Igaku Zasshi; 1999 May; 74(3):249-56. PubMed ID: 10422568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occult colon cancer with initial cutaneous metastatic manifestation: PET/CT detection.
    Nguyen VX; Nguyen BD; Ram PC
    Clin Nucl Med; 2012 May; 37(5):506-8. PubMed ID: 22475906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. F-18 FDG PET/CT detection of mediastinal malignancy in a patient with dermatomyositis.
    Liau N; Ooi C; Reid C; Kirkwood ID; Bartholomeusz D
    Clin Nucl Med; 2007 Apr; 32(4):304-5. PubMed ID: 17413581
    [No Abstract]   [Full Text] [Related]  

  • 51. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
    Prowse SJ; Shaw R; Ganeshan D; Prowse PM; Hanlon R; Lewis-Jones H; Wieshmann H
    J Laryngol Otol; 2013 Aug; 127(8):780-7. PubMed ID: 23919968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography: useful in detecting metastatic cancer of unknown primary site.
    Ruiz-Ruiz FJ; Saenz-Abad D; Hualde-Enguita AM; Morales-Rull JL
    Singapore Med J; 2005 Jun; 46(6):302-3. PubMed ID: 15902359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of occult neoplasia in a patient with dermatomyositis using [
    Ye Z; Yao Y; Yin J; Kou Y; Zhao M; Cheng Z
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):119-120. PubMed ID: 38159845
    [No Abstract]   [Full Text] [Related]  

  • 56. FDG-avid venous malformation could mimic malignancy on 18F-FDG PET/CT.
    Mojtahedi A; Grewal RK; Ulaner GA
    Clin Nucl Med; 2013 Oct; 38(10):826-8. PubMed ID: 24107816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Positron emission tomography/computed tomography in patients with cancer of unknown primary origin].
    Lucić SM; Lucić MA; Peter A; Jovanović D; Vucaj-Cirilović V
    Acta Chir Iugosl; 2009; 56(4):159-64. PubMed ID: 20420014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
    Wang G; Wu Y; Zhang W; Li J; Wu P; Xie C
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):65-71. PubMed ID: 23374557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.